Knockdown of MTHFD2 in breast cancer cells reduced tumor growth and affected many important metabolic pathways, indicating that MTHFD2 might be a central metabolic enzyme in cancer cells [21]. This evidence concerns the gene MTHFD2 and breast carcinoma.